GSK gets a lift from Pfizer and COVID-19

1 May 2020 - Deborah Wilkes

Premium

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 46% at constant exchange rates in the first quarter of 2020, following consolidation of Pfizer’s Consumer Healthcare products and the COVID-19 pandemic.

Click tags below for more information on topics:

GlaxoSmithKline COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: